I think Bristol-Myers is an excellent takeover candidate. It has a bloated cost structure and some really good mid- to late-stage products. |
I think if they lose it really creates a negative vibe for the stock. |
I'd hate to bet against Mark Lanier. He knows how to beat them. I would say the odds are probably against Merck in this case. |
Off the top of my head, $1.3 billion sounds like a lot of money. I think it will be a billion dollar drug but it will take some time. |
The quarter was OK but I see no reason to buy the stock, |
The study certainly isn't ideal for Pfizer. There were some positives for Pfizer, and they will have to go out and do some education (on them). |
You are not going to be able to watch a television show without seeing a commercial for a sleeping pill. |